Related Experiment Video
Updated: Nov 9, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19
Kristin Stawiarski1, Ariane Loutoo1, Leah Velardi1
1Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, United States of America.
Insights
This study explored a d-dimer driven approach to prevent blood clots in hospitalized COVID-19 patients. This method identified no deep vein thrombosis in patients upon discharge, suggesting effective prophylaxis.
Area of Science:
- Internal Medicine
- Cardiology
- Infectious Diseases
Background:
- COVID-19 is associated with a hypercoagulable state, increasing the risk of venous thromboembolism (VTE).
- Early deaths in COVID-19 patients have been linked to undetected VTE.
- Optimal VTE prophylaxis strategies for hospitalized COVID-19 patients remain under investigation.
Abstract:
COVID-19 induces a hypercoagulable state with early case reports of death from undetected venous thromboembolism. Various protocols and consensus statements have been proposed to address the optimal prophylaxis strategy for hospitalized patients. We offer our single institution experience with a d-dimer driven prophylaxis model with no deep vein thrombosis identified on discharge lower extremity ultrasounds.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

